We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$15B
AUM Growth
+$614M
Cap. Flow
-$689M
Cap. Flow %
-4.6%
Top 10 Hldgs %
9.86%
Holding
499
New
33
Increased
63
Reduced
287
Closed
34

Top Sells

Rank Stock Value
1
PODD icon
Insulet
PODD
+$86.4M
2
SAGE
Sage Therapeutics
SAGE
+$56.2M
3
WEC icon
WEC Energy
WEC
+$49.5M
4
AOS icon
A.O. Smith
AOS
+$48.9M
5
CHRW icon
C.H. Robinson
CHRW
+$41.8M

Sector Composition

Rank Sector Weight
1 Technology 21.48%
2 Healthcare 17.37%
3 Industrials 15.16%
4 Consumer Discretionary 13.51%
5 Financials 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KURA icon
251
Kura Oncology
KURA
$792M
$20.7M 0.14%
1,502,217
EGP icon
252
EastGroup Properties
EGP
$11.2B
$20.6M 0.14%
155,416
AEO icon
253
American Eagle Outfitters
AEO
$2.87B
$20.3M 0.14%
1,381,750
-74,025
-5% -$1.13M
ATRA icon
254
Atara Biotherapeutics
ATRA
$73.1M
$20.1M 0.13%
48,810
PGNX
255
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$20.1M 0.13%
3,948,024
CSGP icon
256
CoStar Group
CSGP
$11.6B
$20M 0.13%
+333,500
New +$19.5M
CCL icon
257
Carnival Corporation Ltd
CCL
$38B
$19.9M 0.13%
391,040
-7,645
-2% -$342K
V icon
258
Visa
V
$683B
$19.8M 0.13%
105,600
-7,400
-7% -$1.33M
EW icon
259
Edwards Lifesciences
EW
$49.5B
$19.8M 0.13%
254,250
+58,950
+30% +$4.6M
SMPL icon
260
Simply Good Foods
SMPL
$921M
$19.7M 0.13%
+690,142
New +$18.2M
EXP icon
261
Eagle Materials
EXP
$6.33B
$19.2M 0.13%
212,050
-2,200
-1% -$202K
HII icon
262
Huntington Ingalls Industries
HII
$12.8B
$19M 0.13%
75,825
+13,950
+23% +$3.31M
UHAL icon
263
U-Haul Holding Co
UHAL
$13.8B
$19M 0.13%
505,750
+117,500
+30% +$4.46M
MSI icon
264
Motorola Solutions
MSI
$72B
$18.9M 0.13%
117,000
-1,225
-1% -$202K
EVRG icon
265
Evergy
EVRG
$19.2B
$18.7M 0.12%
286,835
-5,608
-2% -$358K
HALO icon
266
Halozyme
HALO
$9.77B
$18.7M 0.12%
1,052,974
DRI icon
267
Darden Restaurants
DRI
$23.4B
$18.7M 0.12%
171,225
-33,225
-16% -$3.77M
FOXF icon
268
Fox Factory Holding Corp
FOXF
$732M
$18.5M 0.12%
266,083
-42,926
-14% -$2.77M
GCO icon
269
Genesco
GCO
$423M
$18.4M 0.12%
384,027
-132,063
-26% -$5.48M
FOLD
270
DELISTED
Amicus Therapeutics
FOLD
$18.1M 0.12%
1,859,320
UNH icon
271
UnitedHealth
UNH
$382B
$17.8M 0.12%
60,700
-4,200
-6% -$1.1M
P
272
Everpure Inc
P
$25.4B
$17.7M 0.12%
+1,036,425
New +$18.3M
SAVE
273
DELISTED
Spirit Airlines, Inc.
SAVE
$17.7M 0.12%
439,900
-68,450
-13% -$2.6M
MA icon
274
Mastercard
MA
$506B
$17.6M 0.12%
58,930
-4,100
-7% -$1.16M
JNJ icon
275
Johnson & Johnson
JNJ
$622B
$17.6M 0.12%
120,540
-20,957
-15% -$2.84M

Similar funds

Carillon Tower Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Carillon Tower Advisers held 499 positions worth $15B, up 4.3% from $14.4B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Carillon Tower Advisers withdrew a net $689M in Q4 2019, closing 34 positions and reducing 287 holdings. Its most notable exit was Insulet, an estimated $86.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carillon Tower Advisers opened a new position in Seagen Inc. Common Stock worth $48.8M.

  • Carillon Tower Advisers's largest Q4 2019 buy was Seagen Inc. Common Stock: 426,867 shares worth $48.8M.
  • Carillon Tower Advisers added most to Corpay in Q4 2019, an estimated $58.8M increase.
  • Carillon Tower Advisers's biggest Q4 2019 reduction was WEC Energy, cutting an estimated $49.5M.
  • Carillon Tower Advisers fully exited Insulet in Q4 2019, selling an estimated $86.4M.
  • Carillon Tower Advisers's ten largest holdings make up 9.9% of its $15B portfolio in Q4 2019.
  • Carillon Tower Advisers opened 33 new positions and closed 34 in Q4 2019.
  • Carillon Tower Advisers's portfolio value rose 4.3% quarter-over-quarter to $15B.

Based on Carillon Tower Advisers's 13F filing for Q4 2019, filed 11 Feb 2020.